Ghent, Belgium
Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics.
14
Total Investments
10
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
About Novalis Biotech
Recent Investments (14)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed Round | •••••• | Mar 2024 | |
| Series A | •••••• | Feb 2024 | |
| Seed | •••••• | Feb 2024 | |
| Early VC | •••••• | Sep 2023 | |
| Seed Round | •••••• | Feb 2023 | |
•••• ••••
|
Seed Round - C | •••••• | Jan 2023 |
|
•••• ••••
|
Series A | •••••• | Nov 2022 |
|
•••• ••••
|
Seed Round | •••••• | Oct 2022 |
|
•••• ••••
|
Series A | •••••• | Sep 2022 |
|
•••• ••••
|
Seed Round | •••••• | May 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
